GlassScriptPhysician profile
Jessica Oswald
NPI 1427315118
$89,893.16
in general payments reported to CMS, 2019-2025
15 companies · $16K in 2025
The $16K reported for 2025 was more than what 97% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,912 · 2020: $275 · 2021: $18K · 2022: $168 · 2023: $10K · 2024: $43K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $60K · Travel and Lodging: $6,470 · Food and Beverage: $2,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,466.00 |
| Travel and Lodging | $6,469.84 |
| Food and Beverage | $2,314.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $60,902.42 | 2023-2025 | |
| Grt US Holding, INC. | $18,258.72 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $7,708.72 | 2022-2025 | Xifaxan, Relistor |
| Abbott Laboratories | $1,217.84 | 2019-2024 | Eterna |
| Boston Scientific Corporation | $726.04 | 2019-2025 | General - Therapies |
| Spr Therapeutics, INC | $326.88 | 2019-2025 | Sprint Pns System |
| Vertiflex, INC. | $198.90 | 2019 | |
| Averitas Pharma INC. | $198.24 | 2024 | Qutenza |
| Bioness INC | $142.45 | 2019 | |
| Vertos Medical, INC. | $62.24 | 2021 | |
| Nevro Corp. | $48.47 | 2019 | |
| Merz North America, INC. | $34.74 | 2020 | |
| Avanos Medical | $33.05 | 2022 | |
| Medtronic, INC. | $19.62 | 2022 | |
| Ambu INC. | $14.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Oswald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.